Edward Kraus

Professor

1983 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Edward Kraus is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Kidney Medicine & Life Sciences
Kidney Transplantation Medicine & Life Sciences
Allografts Medicine & Life Sciences
Transplants Medicine & Life Sciences
Tissue Donors Medicine & Life Sciences
Antibodies Medicine & Life Sciences
Biopsy Medicine & Life Sciences
Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2018

Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications

Schinstock, C. A., Sapir-Pichhadze, R., Naesens, M., Batal, I., Bagnasco, S. M., Bow, L., Campbell, P., Clahsen-van Groningen, M. C., Cooper, M., Cozzi, E., Dadhania, D., Diekmann, F., Budde, K., Lower, F., Orandi, B. J., Rowshani, A. T., Cornell, L. & Kraus, E., Jan 1 2018, (Accepted/In press) In : American Journal of Transplantation.

Research output: Contribution to journalArticle

Kidney Transplantation
Antibodies
Therapeutics
Surveys and Questionnaires
Negative Staining

Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?

Philogene, M. C., Zhou, S., Lonze, B. E., Bagnasco, S. M., Alasfar, S., Montgomery, R. A., Kraus, E., Jackson, A., Leffell, M. S. & Zachary, A. A., Jan 1 2018, (Accepted/In press) In : Human Immunology.

Research output: Contribution to journalArticle

Angiotensin Type 1 Receptor
Transplants
Antibodies
Transplantation
Biopsy

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

Haas, M., Loupy, A., Lefaucheur, C., Roufosse, C., Glotz, D., Seron, D., Nankivell, B. J., Halloran, P. F., Colvin, R. B., Akalin, E., Alachkar, N., Bagnasco, S. M., Bouatou, Y., Becker, J. U., Cornell, L. D., van Huyen, J. P. D., Gibson, I. W., Kraus, E., Mannon, R. B., Naesens, M. & 9 others, Nickeleit, V., Nickerson, P., Segev, D., Singh, H. K., Stegall, M., Randhawa, P., Racusen, L. C., Solez, K. & Mengel, M., Feb 1 2018, In : American Journal of Transplantation. 18, 2, p. 293-307 15 p.

Research output: Contribution to journalArticle

Clinical Trials
Kidney
Atrophy
Antibodies
Fibrosis

Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: A retrospective study

Lonze, B. E., Bae, S., Kraus, E., Holechek, M. J., King, K. E., Alachkar, N., Naqvi, F., Dagher, N. N., Sharif, A., Desai, N. M., Segev, D. & Montgomery, R. A., 2017, (Accepted/In press) In : Transplant International.

Research output: Contribution to journalArticle

Retrospective Studies
Transplants
Kidney
Antibodies
Incidence

Severe chronic norovirus diarrheal disease in transplant recipients: Clinical features of an under-recognized syndrome

Avery, R., Lonze, B. E., Kraus, E., Marr, K. & Montgomery, R. A., Apr 1 2017, In : Transplant Infectious Disease. 19, 2, e12674.

Research output: Contribution to journalArticle

Norovirus
Diarrhea
nitazoxanide
Plasmapheresis
Transplants